FDA approves anti-obesity drug as first sleep apnea medication
The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...
Pharmaceutical Technology26m
FDA approves Lilly’s obesity med Zepbound to treat obstructive sleep apnoea
Lilly’s Zepbound has become the first prescription medicine approved to treat adults with moderate to severe obstructive sleep apnoea (OSA) and obesity.
healthday33m
GLP-1 Zepbound Is Approved As First Drug For Sleep Apnea
The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating o ...
Zawya48m
Wall St futures choppy as investors digest Fed's rate cut view
The United States Congress passed spending legislation early on Saturday, minutes after the funding's expiration, which could ...
Eli Lilly, Novo Nordisk Stocks Rise. One of These Obesity Drugmakers Just Hit a Landmark.
Lilly and Novo still dominate the market for weight-loss and diabetes drugs, but the race is heating up in more ways than one ...